Indonesia’s Kimia Farma acquires majority stake in Saudi’s Dawaa Medical for $10m

Kimia Farma signs shareholder agreement with Dawaa Medical Limited

Indonesian state-owned pharmaceutical company Kimia Farma has announced today that it has acquired 60% stake in Saudi Arabia’s Dawaa Medical Limited Company for $10.1 million in a share subscription investment scheme.

Continue reading this story with a subscription to DealStreetAsia.


Should your colleagues be reading this article too? Contact us for corporate subscriptions at